Gut microbiota metabolite butyric acid alleviated Klebsiella Pneumoniae induced lung injury by regulating CX3CR1+ NK via PI3K/AKT pathway

Abstract

Background: The expression of CX3CR1 is regulated by the gut microbiota and is correlated with the prognosis of sepsis in patients. However, the underlying mechanism has remained uncertain. This study aims to explore the role of gut microbiota components in regulating CX3CR1 expression and its impact on pneumonia-induced lung injury during sepsis. Methods: Mice were fed a mixture of antibiotics to establish a pseudogerm-free mouse model and then infected with Klebsiella pneumoniae. Fecal microbiota transplantation (FMT) was performed on microbiota-depleted mice, and 16S rRNA gene sequencing and targeted metabolomics were used to identify the key metabolites. Flow cytometry was employed to analyze the phenotypes of natural killer (NK) cells. Butyric acid was added as a supplement for rescue. Next, NK92 cells were pretreated with butyric acid to explore the potential signaling pathways involved. Results: In the animal study, we revealed that the expression of CX3CR1 on NK cells depended on the intestinal microbiota and its metabolites, which were related to the survival rates of gut microbiota-depleted mice after K. pneumoniae infection. FMT increased the percentage of CX3CR1+ NK cells in the lungs of these mice, restored the disordered microbiota and metabolites, and alleviated the lung injury induced by infection. Among the metabolites, butyric acid was identified as the key metabolite and was shown to increase the proportion of CX3CR1+ NK cells and interferon (IFN)-γ secretion, reduce bacterial loads, increase lung tissue damage, and increase survival rates. In vitro, butyric acid activated the PI3K/AKT pathway in NK92 cells, promoted CX3CR1 expression, and enhanced NK cell activity and migration ability. Conclusions: We concluded that butyric acid alleviated K. pneumoniae-induced lung injury by regulating CX3CR1+ NK cells via the PI3K/AKT pathway.

Keywords

Klebsiella pneumoniae / Acute lung injury / Gut microbiota / Butyric acid / Natural killer cells

References

[1] Chen AX, Simpson SQ, Pallin DJ. Sepsis guidelines. N Engl J Med 2019; 380:1369-71. https://doi.org/10.1056/NEJMclde1815472.

[2] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). Jama 2016; 315:801-10. https://doi.org/10.1001/jama.2016.0287.

[3] Dickson RP. The microbiome and critical illness. Lancet Respir Med 2016; 4:59-72. https://doi.org/10.1016/s2213-2600(15)00427-0.

[4] Caballero-Flores G, Pickard JM, Núñez G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat Rev Microbiol 2022; 21:347-60. https://doi.org/10.1038/s41579-022-00833-7.

[5] Wu M, Mi B, Liu L, Ma H, Jiang C, Jiang S, et al. Genetic polymorphisms, biomarkers and signaling pathways associated with septic. Burns Trauma 2024; 12:tkae006. https://doi.org/10.1093/burnst/tkae006.

[6] Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol 2017; 2:135-43. https://doi.org/10.1016/s2468-1253(16)30119-4.

[7] Agudelo-Ochoa GM, Valdés-Duque BE, Giraldo-Giraldo NA, Jaillier-Ramírez AM, Giraldo-Villa A, Acevedo-Castaño I, et al. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes 2020; 12:e-1707610. https://doi.org/10.1080/19490976.2019.1707610.

[8] Sun S, Wang D, Dong D, Xu L, Xie M, Wang Y, et al. Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis. Crit Care 2023; 27:127. https://doi.org/10.1186/s13054-023-04412-x.

[9] Long X, Mu S, Zhang J, Xiang H, Wei W, Sun J, et al. Global signatures of the microbiome and metabolome during hospitalization of septic patients. Shock 2023; 59:716-24. https://doi.org/10.1097/shk.0000000000002117.

[10] Mu S, Xiang H, Wang Y, Wei W, Long X, Han Y, et al. The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut. Crit Care 2022; 26:68. https://doi.org/10.1186/s13054-022-03943-z.

[11] Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of gram-negative bacteremia. Clin Microbiol Rev 2021;34:34. https://doi.org/10.1128/cmr.00234-20.

[12] Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti-Infect Ther 2018; 16:749-61. https://doi.org/10.1080/14787210.2018.1522249.

[13] Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 2016; 80:629-61. https://doi.org/10.1128/mmbr.00078-15.

[14] Xu X, Weiss ID, Zhang HH, Singh SP, Wynn TA, Wilson MS, et al. Conventional nk cells can produce il-22 and promote host defense in klebsiella pneumoniae pneumonia. J Immunol 2014; 192:1778-86. https://doi.org/10.4049/jimmunol.1300039.

[15] Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM, Standiford TJ. Cpg oligodeoxynucleotides stimulate protective innate immunity against pulmonary klebsiella infection. J Immunol 2004; 173:5148-55. https://doi.org/10.4049/jimmunol.173.8.5148.

[16] Ivin M, Dumigan A, de Vasconcelos FN, Ebner F, Borroni M, Kavirayani A, et al. Natural killer cell-intrinsic type i ifn signaling controls klebsiella pneumoniae growth during lung infection. PLoS Pathog 2017; 13:e1006696. https://doi.org/10.1371/journal.ppat.1006696.

[17] Bengoechea JA, Sa PJ. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 2019; 43:123-44. https://doi.org/10.1093/femsre/fuy043.

[18] Schneider KM, Bieghs V, Heymann F, Hu W, Dreymueller D, Liao L, et al. Cx3cr1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology 2015; 62:1405-16. https://doi.org/10.1002/hep.27982.

[19] Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 2000; 164:3368-76. https://doi.org/10.4049/jimmunol.164.6.3368.

[20] Brand S, Sakaguchi T, Gu X, Colgan SP, Reinecker HC . Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 2002; 122:166-77. https://doi.org/10.1053/gast.2002.30329.

[21] Ishida Y, Hayashi T, Goto T, Kimura A, Akimoto S, Mukaida N, et al. Essential involvement of cx3cr1-mediated signals in the bactericidal host defense during septic peritonitis. J Immunol 2008; 181:4208-18. https://doi.org/10.4049/jimmunol.181.6.4208.

[22] Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor cx3cr1, which mediates both leukocyte migration and adhesion. Cell 1997; 91:521-30. https://doi.org/10.1016/s0092-8674(00)80438-9.

[23] Emal D, Rampanelli E, Stroo I, Butter LM, Teske GJ, Claessen N, et al. Depletion of gut microbiota protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2017; 28:1450-61. https://doi.org/10.1681/asn.2016030255.

[24] Jin X, Jian Z, Chen X, Ma Y, Ma H, Liu Y, et al. Short chain fatty acids prevent glyoxylate-induced calcium oxalate stones by gpr43-dependent immunomodulatory mechanism. Front Immunol 2021; 12:729382. https://doi.org/10.3389/fimmu.2021.729382.

[25] Friggeri A, Cazalis MA, Pachot A, Cour M, Argaud L, Allaouchiche B, et al. Decreased cx3cr1 messenger rna expression is an independent molecular biomarker of early and late mortality in critically ill patients. Crit Care 2016; 20:204. https://doi.org/10.1186/s13054-016-1362-x.

[26] Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by nod1 enhances systemic innate immunity. Nat Med 2010; 16:228-31. https://doi.org/10.1038/nm.2087.

[27] Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJTH, de Boer JD, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65:575-83. https://doi.org/10.1136/gutjnl-2015-309728.

[28] Marcon R, Claudino RF, Dutra RC, Bento AF, Schmidt EC, Bouzon ZL, et al. Exacerbation of dss-induced colitis in mice lacking kinin b(1) receptors through compensatory up-regulation of kinin b(2) receptors: the role of tight junctions and intestinal homeostasis. Br J Pharmacol 2013; 168:389-402. https://doi.org/10.1111/j.1476-5381.2012.02136.x.

[29] Gonzaga R, Matzinger P, Perez-Diez A. Resident peritoneal nk cells. J Immunol 2011; 187:6235-42. https://doi.org/10.4049/jimmunol.1101540.

[30] Schloss PD, Gevers D, Westcott SL. Reducing the effects of pcr amplification and sequencing artifacts on 16s rrna-based studies. PLoS One 2011; 6:e27310. https://doi.org/10.1371/journal.pone.0027310.

[31] Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.

[32] Zhang YD, Zhou GL, Wang L, MHEM B, Markevych I, Heinrich J, et al. Greenspace and human microbiota: a systematic review. Environ Int 2024 May; 187:108662. https://doi.org/10.1016/j.envint.2024.108662.

[33] Lai HC, Chang CJ, Lin CS, Wu TR, Hsu YJ, Wu TS, et al. Nk cell-derived ifn-γ protects against nontuberculous mycobacterial lung infection. J Immunol 2018; 201:1478-90. https://doi.org/10.4049/jimmunol.1800123.

[34] Pachot A, Cazalis MA, Venet F, Turrel F, Faudot C, Voirin N, et al. Decreased expression of the fractalkine receptor cx3cr1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol 2008; 180:6421-9. https://doi.org/10.4049/jimmunol.180.9.6421.

[35] Sciumè G, De Angelis G, Benigni G, Ponzetta A, Morrone S, Santoni A, et al. Cx3cr1 expression defines 2 klrg1+ mouse nk-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 2011; 117:4467-75. https://doi.org/10.1182/blood-2010-07-297101.

[36] Ponzetta A, Sciumè G, Benigni G, Antonangeli F, Morrone S, Santoni A, et al. Cx3cr1 regulates the maintenance of klrg1+ nk cells into the bone marrow by promoting their entry into circulation. J Immunol 2013; 191:5684-94. https://doi.org/10.4049/jimmunol.1300090.

[37] Di Vito C, Mikulak J, Zaghi E, Pesce S, Marcenaro E, Mavilio D. Nk cells to cure cancer. Semin Immunol 2019; 41:101272. https://doi.org/10.1016/j.smim.2019.03.004.

[38] Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical nk cells in patients with cancer. Blood 2005; 105:3051-7. https://doi.org/10.1182/blood-2004-07-2974.

[39] Xiao L, Cen D, Gan H, Sun Y, Huang N, Xiong H, et al. Adoptive transfer of nkg2d car mrna-engineered natural killer cells in colorectal cancer patients. Mol Ther 2019; 27:1114-25. https://doi.org/10.1016/j.ymthe.2019.03.011.

[40] Gibbert K, Joedicke JJ, Meryk A, Trilling M, Francois S, Duppach J, et al. Interferon-alpha subtype 11 activates nk cells and enables control of retroviral infection. PLoS Pathog 2012; 8:e1002868. https://doi.org/10.1371/journal.ppat.1002868.

[41] Li T, Wang J, Wang Y, Chen Y, Wei H, Sun R, et al. Respiratory influenza virus infection induces memory-like liver nk cells in mice. J Immunol 2017; 198:1242-52. https://doi.org/10.4049/jimmunol.1502186.

[42] Münz C, Chijioke O. Natural killer cells in herpesvirus infections. F1000Res 2017; 6:1231. https://doi.org/10.12688/f1000research.11197.1.

[43] Hoegl S, Ehrentraut H, Brodsky KS, Victorino F, Golden-Mason L, Eltzschig HK, et al. Nk cells regulate cxcr2+ neutrophil recruitment during acute lung injury. J Leukoc Biol 2017; 101:471-80. https://doi.org/10.1189/jlb.3A0516-227R.

[44] Ivanova DL, Mundhenke TM, Gigley JP. The il-12-and il-23-dependent nk cell response is essential for protective immunity against secondary toxoplasma gondii infection. J Immunol 2019; 203:2944-58. https://doi.org/10.4049/jimmunol.1801525.

[45] Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature 2016; 535:75-84. https://doi.org/10.1038/nature18848.

[46] Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 2019; 50:432-45.e7. https://doi.org/10.1016/j.immuni.2018.12.018.

[47] Lou X, Xue J, Shao R, Mo C, Wang F, Chen G. Postbiotics as potential new therapeutic agents for sepsis. Burns Trauma 2023; 11:tkad022. https://doi.org/10.1093/burnst/tkad022.

[48] Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-il-18 axis. Nat Commun 2023; 14:1710. https://doi.org/10.1038/s41467-023-37419-7.

[49] Zaiatz-Bittencourt V, Jones F, Tosetto M, Scaife C, Cagney G, Jones E, et al. Butyrate limits human natural killer cell effector function. Sci Rep 2023; 13:2715. https://doi.org/10.1038/s41598-023-29731-5.

[50] Ali AK, Nandagopal N, Lee SH. Il-15-pi3k-akt-mtor: a critical pathway in the life journey of natural killer cells. Front Immunol 2015; 6:355. https://doi.org/10.3389/fimmu.2015.00355.

[51] Tan S, Xu Y, Wang Z, Wang T, Du X, Song X, et al. Tim-3 hampers tumor surveillance of liver-resident and conventional nk cells by disrupting pi3k signaling. Cancer Res 2020; 80:1130-42. https://doi.org/10.1158/0008-5472.Can-19-2332.

[52] Oak JS, Fruman DA. Role of phosphoinositide 3-kinase signaling in autoimmunity. Autoimmunity 2007; 40:433-41. https://doi.org/10.1080/08916930701464780.

[53] Jo SH, Kim SD, Kim JM, Lee HY, Lee SY, Shim JW, et al. Lysophosphatidylglycerol stimulates chemotactic migration in human natural killer cells. Biochem Biophys Res Commun 2008; 372:147-51. https://doi.org/10.1016/j.bbrc.2008.05.004.

[54] Kunikata T, Torigoe K, Ushio S, Okura T, Ushio C, Yamauchi H, et al. Constitutive and induced il-18 receptor expression by various peripheral blood cell subsets as determined by anti-hil-18r monoclonal antibody. Cell Immunol 1998; 189:135-43. https://doi.org/10.1006/cimm.1998.1376.

[55] Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, et al. Differential cytokine and chemokine gene expression by human nk cells following activation with il-18 or il-15 in combination with il-12: implications for the innate immune response. J Immunol 1999; 162:4511-20. https://doi.org/10.4049/jimmunol.162.8.4511.

[56] Saw G, Krishna K, Gupta N, Soong TW, Mallilankaraman K, Sajikumar S, et al. Epigenetic regulation of microglial phosphatidylinositol 3-kinase pathway involved in long-term potentiation and synaptic plasticity in rats. Glia 2020; 68:656-69. https://doi.org/10.1002/glia.23748.

[57] Zhou Z, Xu N, Matei N, McBride DW, Ding Y, Liang H, et al. Sodium butyrate attenuated neuronal apoptosis via gpr41/gβγ/pi3k/akt pathway after mcao in rats. J Cereb Blood Flow Metab 2021; 41:267-81. https://doi.org/10.1177/0271678x20910533.

[58] Rossi LE, Avila DE, Spallanzani RG, Ziblat A, Fuertes MB, Lapyckyj L, et al. Histone deacetylase inhibitors impair nk cell viability and effector functions through inhibition of activation and receptor expression. J Leukoc Biol 2012; 91:321-31. https://doi.org/10.1189/jlb.0711339.

[59] Werkmeister JA, Pross HF, Roder JC. Modulation of k562 cells with sodium butyrate. Association of impaired nk susceptibility with sialic acid and analysis of other parameters. Int J Cancer 1983; 32:71-8. https://doi.org/10.1002/ijc.2910320112.

[60] Amin MR, Dudeja PK, Ramaswamy K, Malakooti J. Involvement of sp1 and sp3 in differential regulation of human nhe3 promoter activity by sodium butyrate and ifn-gamma/tnf-alpha. Am J Physiol Gastrointest Liver Physiol 2007; 293:G374-82. https://doi.org/10.1152/ajpgi.00128.2007.

[61] Kim HS, Whang SY, Woo MS, Park JS, Kim WK, Han IO. Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia. J Neuroimmunol 2004; 151:85-93. https://doi.org/10.1016/j.jneuroim.2004.02.006.

[62] Weber TE, Kerr BJ. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol 2006; 113:139-47. https://doi.org/10.1016/j.vetimm.2006.04.006.